Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase
- PMID: 8631303
- PMCID: PMC450280
Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase
Abstract
The Tpl-2 protein serine/threonine kinase was originally identified, in a C-terminally deleted form, as the product of an oncogene associated with the progression of Moloney murine leukemia virus-induced T cell lymphomas in rats. The kinase domain of Tpl-2 is homologous to the Saccharomyces cerevisiae gene product, STE11, which encodes a MAP kinase kinase kinase. This suggested that Tpl-2 might have a similar activity. Consistent with this hypothesis, immunoprecipitated Tpl-2 and Tpl-2deltaC (a C-terminally truncated mutant) phosphorylated and activated recombinant fusion proteins of the mammalian MAP kinase kinases, MEK-1 and SEK-1, in vitro. Furthermore, transfection of Tpl-2 into COS-1 cells or Jurkat T cells. markedly activated the MAP kinases, ERK-1 and SAP kinase (JNK), which are substrates for MEK-1 and SEK-1, respectively. Tpl-2, therefore, is a MAP kinase kinase kinase which can activate two MAP kinase pathways. After Raf and Mos, Tpl-2 is the third serine/threonine oncoprotein kinase that has been shown to function as a direct activator of MEK-1.
Similar articles
-
Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells.Oncogene. 1999 Feb 18;18(7):1391-400. doi: 10.1038/sj.onc.1202431. Oncogene. 1999. PMID: 10050876
-
Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.Oncogene. 1998 Nov 19;17(20):2609-18. doi: 10.1038/sj.onc.1202460. Oncogene. 1998. PMID: 9840924
-
Novel components of mammalian stress-activated protein kinase cascades.Biochem Soc Trans. 1997 May;25(2):491-8. doi: 10.1042/bst0250491. Biochem Soc Trans. 1997. PMID: 9191142 Review. No abstract available.
-
Control of the ERK MAP kinase cascade by Ras and Raf.Cancer Surv. 1996;27:101-25. Cancer Surv. 1996. PMID: 8909797 Review.
-
Mesoderm induction in Xenopus caused by activation of MAP kinase.Nature. 1995 Jul 6;376(6535):58-62. doi: 10.1038/376058a0. Nature. 1995. PMID: 7541116
Cited by
-
The Morpho-Molecular Landscape of Spitz Neoplasms.Int J Mol Sci. 2022 Apr 11;23(8):4211. doi: 10.3390/ijms23084211. Int J Mol Sci. 2022. PMID: 35457030 Free PMC article. Review.
-
IKBKE-driven TPL2 and MEK1 phosphorylations sustain constitutive ERK1/2 activation in tumor cells.EXCLI J. 2022 Feb 18;21:436-453. doi: 10.17179/excli2021-4578. eCollection 2022. EXCLI J. 2022. PMID: 35391917 Free PMC article.
-
Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease.Cells. 2021 Dec 20;10(12):3589. doi: 10.3390/cells10123589. Cells. 2021. PMID: 34944097 Free PMC article.
-
Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities.Cancers (Basel). 2021 Oct 31;13(21):5481. doi: 10.3390/cancers13215481. Cancers (Basel). 2021. PMID: 34771644 Free PMC article. Review.
-
Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.Oncogene. 2020 Nov;39(47):7034-7050. doi: 10.1038/s41388-020-01481-y. Epub 2020 Sep 28. Oncogene. 2020. PMID: 32989258 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous